Heart health after severe pneumonia
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study looks at how heart health changes in people who have recovered from severe pneumonia, including COVID-19. It compares survivors to healthy people and those with heart risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You either have no history of severe pneumonia or are a survivor of severe COVID-19 or community-acquired pneumonia.
- If you have no severe pneumonia history, you must have few or several health conditions like obesity, diabetes, high cholesterol, or high blood pressure.
- If you are a COVID-19 survivor, you were treated with dexamethasone and had lung changes on imaging.
- If you are a community-acquired pneumonia survivor, you were treated in a hospital ward or ICU.
- You are not pregnant or breastfeeding, and your doctor thinks you are likely to live at least 6 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a heart MRI to look for leftover (healing) changes in heart tissue after COVID-19. It may help researchers better understand what ongoing heart effects can happen after infection.
This study looks at how pneumonia affects the long-term health of your heart and lungs by studying the germs that live in your body. It may help doctors understand why some people get worse and how to better protect your heart after a serious infection.
This study looks at how COVID-19 may affect the lungs, heart, and kidneys in the months or years after the infection. It compares three groups: people who never had COVID, people who had COVID but recovered without organ problems, and people who had organ problems during COVID. The goal is to understand what long-term complications might arise.
This trial looks at how persistent heart-related changes after a past COVID infection may be affected by study treatments. It mainly seeks people who are stable enough for follow-up visits and heart imaging, and who are not already on the specific heart medications required.
This trial looks at pneumonia that happens in the hospital after coronary artery bypass surgery. It aims to understand who is at risk and how to better prevent or treat it.
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
Hear when a new COVID-19 Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.